EGFR and cancer: In the absence of a Ras mutation, increased Ras activity in human cancer cells frequently results from gene amplification [137,138], gene overexpression [139], or an increase in activity of upstream signals from tyrosine kinase growth factor receptors such as Her2 and EGF receptor (EGFR) [140,141].